| LEVODOPA | None | ||
| 42MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| INBRIJA is an aromatic amino acid indicated for the intermittent treatment of OFF episodes in patients with Parkinson’s disease treated with carbidopa/levodopa. | |||
|
Yes
| |||
| INBRIJA | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 | Patent 16 | Patent 17 | Patent 18 | Patent 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||||||||||||
| ******** ********** **** ***** ** ******** *** ********* *** | ******** ********** **** ***** ** ******** *** ********* *** | ******** ********** **** ***** ** ******** *** ********* *** | ******** ********** **** ***** ** ******** *** ********* *** | ******* *** ********* ***** ****** ** ***** ************ ** * *********'* ******* ******* | ********* ******** *** ******** | ****** ********* ******** ** * ***** *********** **** ******* | ****** ********* ******** ** * ***** *********** **** ******* | ********* ******** ** ******** ********* ** *** ******* ******* ****** | ********* ******** ** ******** ********* ** *** ******* ******* ****** | ********* ******** ** ******** ********* ** *** ******* ******* ****** | ********** ****** *** ****** | **** ********* ******** ** * ***** *********** **** ******* | ****** ********* ******** ** * ***** *********** **** ******* | *********** ************ *** ********* ******** | ********* ******** *** ******** | ********* ******** *** ******** | ********* ******** *** ******** | *********** ************ *** ********* ******** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|